Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.

Saved in:
Bibliographic Details
Title: Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.
Authors: Brahmer, Julie1 brahmju@jhmi.edu, Reckamp, Karen L.2, Baas, Paul3, Crinò, Lucio4, Eberhardt, Wilfried E. E.5,6, Poddubskaya, Elena7, Antonia, Scott8, Pluzanski, Adam9, Vokes, Everett E.10, Holgado, Esther11, Waterhouse, David12, Ready, Neal13, Gainor, Justin14, Frontera, Osvaldo Arén15, Havel, Libor16, Steins, Martin17, Garassino, Marina C.18, Aerts, Joachim G.19, Domine, Manuel20, Paz-Ares, Luis21
Source: New England Journal of Medicine. 7/9/2015, Vol. 373 Issue 2, p123-135. 13p.
Database: Academic Search Ultimate
Be the first to leave a comment!
You must be logged in first